Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Proton Rahman

Showing results (181-190 of 260) with videos related to

Pageof 26
Sort By:
BMJ Open|September 1, 2017
Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registryProton Rahman, Michel Zummer, Louis Bessette, et al.
The Journal of Rheumatology|November 3, 2010
Genetic studies of ankylosing spondylitis in Koreans confirm associations with ERAP1 and 2p15 reported in white patientsSo-Young Bang, Tae-Hwan Kim, Bitnara Lee, et al.
Annals of the Rheumatic Diseases|May 10, 2015
Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritisDarren D O'Rielly, Mohammed Uddin, Dianne Codner, et al.
The New England Journal of Medicine|October 1, 2015
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic ArthritisPhilip J Mease, Iain B McInnes, Bruce Kirkham, et al.
Rheumatology and Therapy|December 7, 2020
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X TrialAtul Deodhar, Philip Mease, Proton Rahman, et al.
Rheumatology (Oxford, England)|September 20, 2022
Individual participant data meta-analysis of metabolomics on sustained knee pain in primary osteoarthritis patientsChristie A Costello, Jason S Rockel, Ming Liu, et al.
The Journal of Rheumatology|May 3, 2020
Phenylalanine Is a Novel Marker for Radiographic Knee Osteoarthritis Progression: The MOST StudyGuangju Zhai, Xianbang Sun, Edward W Randell, et al.
The Lancet. Rheumatology|January 25, 2024
Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 studyIain B McInnes, Philip J Mease, Alan J Kivitz, et al.
Rheumatology and Therapy|December 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X TrialsJohn D Reveille, Martin Rudwaleit, Proton Rahman, et al.
Arthritis Research & Therapy|July 15, 2021
Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritisProton Rahman, Philip J Mease, Philip S Helliwell, et al.
Pageof 26

Showing results (181-190 of 260) with videos related to

Sort By:
Pageof 26
BMJ Open|September 1, 2017
Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registryProton Rahman, Michel Zummer, Louis Bessette, et al.
The Journal of Rheumatology|November 3, 2010
Genetic studies of ankylosing spondylitis in Koreans confirm associations with ERAP1 and 2p15 reported in white patientsSo-Young Bang, Tae-Hwan Kim, Bitnara Lee, et al.
Annals of the Rheumatic Diseases|May 10, 2015
Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritisDarren D O'Rielly, Mohammed Uddin, Dianne Codner, et al.
The New England Journal of Medicine|October 1, 2015
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic ArthritisPhilip J Mease, Iain B McInnes, Bruce Kirkham, et al.
Rheumatology and Therapy|December 7, 2020
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X TrialAtul Deodhar, Philip Mease, Proton Rahman, et al.
Rheumatology (Oxford, England)|September 20, 2022
Individual participant data meta-analysis of metabolomics on sustained knee pain in primary osteoarthritis patientsChristie A Costello, Jason S Rockel, Ming Liu, et al.
The Journal of Rheumatology|May 3, 2020
Phenylalanine Is a Novel Marker for Radiographic Knee Osteoarthritis Progression: The MOST StudyGuangju Zhai, Xianbang Sun, Edward W Randell, et al.
The Lancet. Rheumatology|January 25, 2024
Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 studyIain B McInnes, Philip J Mease, Alan J Kivitz, et al.
Rheumatology and Therapy|December 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X TrialsJohn D Reveille, Martin Rudwaleit, Proton Rahman, et al.
Arthritis Research & Therapy|July 15, 2021
Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritisProton Rahman, Philip J Mease, Philip S Helliwell, et al.
Pageof 26